Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Acq. announced
Appointed director
Notes underwriting agrmnt
MedTech Acquisition Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "STANDBY EQUITY PURCHASE AGREEMENT"
08/23/2023 SC 13G Lombard International Assurance S.A. reports a 5.2% stake in TriSalus Life Sciences Inc.
08/22/2023 SC 13G Stansky Michael P reports a 5.3% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023 SC 13D MATLIN DAVID J reports a 8.2% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13G Dewey Christopher C reports a 5.6% stake in TRISALUS LIFE SCIENCES, INC.
08/21/2023 SC 13D Wahlstrom Mats reports a 10.4% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13G MCGREVIN GENE R reports a 5.3% stake in TriSalus Life Sciences, Inc.
08/21/2023 SC 13D Frankenius Equity AB reports a 24.1% stake in TriSalus Life Sciences, Inc.
08/16/2023 8-K Director compensation was amended/approved, Acquisition/merger/asset purchase announced
Docs: "Second Amended and Restated Certificate of Incorporation of TriSalus Life Sciences, Inc",
"Amended and Restated Bylaws of TriSalus Life Sciences, Inc",
"Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of TriSalus Life Sciences, Inc",
"Specimen Common Stock Certificate",
"Specimen Warrant Certificate",
"Description of Common Stock",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023"
08/15/2023 4 Szela Mary T (CEO and President) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 172,500 options to buy @ $11.51, valued at $2M
08/15/2023 3 Szela Mary T (CEO and President) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Stevens Jennifer (Chief Regulatory Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 40,000 options to buy @ $12, valued at $480k
08/14/2023 3 Stevens Jennifer (Chief Regulatory Officer) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Murphy Sean (CFO) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 62,500 options to buy @ $12, valued at $750k
08/14/2023 3 Murphy Sean (CFO) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Marshak Richard (Sr.VP, Corp. Dev. & Strategy) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 40,000 options to buy @ $12, valued at $480k
08/14/2023 3 Marshak Richard (Sr.VP, Corp. Dev. & Strategy) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Katz Steven C (Chief Medical Officer) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 62,500 options to buy @ $12, valued at $750k
08/14/2023 3 Katz Steven C (Chief Medical Officer) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Cox Bryan F. (Chief Scientific & Manufact.) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 40,000 options to buy @ $12, valued at $480k
08/14/2023 3 Cox Bryan F. (Chief Scientific & Manufact.) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 3 Alecxih James (President, Device Technology) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 3 Frankenius Equity AB (10% Owner) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Wahlstrom Mats (10% Owner) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $11.34, valued at $396.9k
08/14/2023 3 Wahlstrom Mats (10% Owner) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 VON ESCHENBACH ANDREW C. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $11.34, valued at $396.9k
08/14/2023 3 VON ESCHENBACH ANDREW C. (Director) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 Singhal Anil K. (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $11.34, valued at $396.9k
08/14/2023 3 Singhal Anil K. (Director) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 MATLIN DAVID J (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Acquired 931,904 shares @ $0
Acquired 1,240,518 options to buy @ $11.5, valued at $14.3M
Granted 35,000 options to buy @ $11.34, valued at $396.9k
Granted 100,000 preferred shares @ $10, valued at $1M
08/14/2023 4 Martin George Kelly (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $11.34, valued at $396.9k
08/14/2023 3 Martin George Kelly (Director) has filed a Form 3 on TriSalus Life Sciences, Inc.
08/14/2023 4 HICKS KERRY R (Director) has filed a Form 4 on TriSalus Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $11.34, valued at $396.9k
08/14/2023 3 HICKS KERRY R (Director) has filed a Form 3 on TriSalus Life Sciences, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy